Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
  1. 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes President and COO gave up 13,954 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 5,904 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Shares withheld for taxes President and COO gave up 23,185 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 1,214 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 28,337 shares (to pay taxes)
  18. 4 Shares withheld for taxes President and CEO gave up 38,451 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Chief Strategy Officer gave up 16,344 shares (to pay taxes)
  20. 4 Grant or award Director acquired 7,915 shares (grant or award)

Page 3 of 38 · 752 filings